This study substantiates the potential of RRTFB as a phytochemo therapeutic strategy for combating obesity, highlighting its ability to mitigate obesity through DNMT3a/SIRT1‐mediated epigenetic regulation, with flavonoids identified as the primary bioactive components. The gene discussed is DNMT3A; the disease is obesity due to melanocortin 4 receptor deficiency.